These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22544184)

  • 1. World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries.
    Bertagnolio S; Penazzato M; Jordan MR; Persaud D; Mofenson LM; Bennett DE;
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S254-60. PubMed ID: 22544184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Rates of Drug Resistance Among Newly Diagnosed HIV-infected Children in the National Prevention of Mother-to-child Transmission Program in Togo.
    Salou M; Butel C; Konou AA; Ekouevi DK; Vidal N; Dossim S; Lawson-Evi K; Nyasenu YT; Singo-Tokofaï A; d'Almeida S; Tchama R; Delaporte E; Prince-David M; Peeters M; Dagnra AY
    Pediatr Infect Dis J; 2016 Aug; 35(8):879-85. PubMed ID: 27167115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of transmitted HIV drug resistance using matched plasma and dried blood spot specimens from voluntary counseling and testing sites in Ho Chi Minh City, Vietnam, 2007-2008.
    Duc NB; Hien BT; Wagar N; Tram TH; Giang le T; Yang C; Wolfe MI; Hien NT; Tuan NA
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S343-7. PubMed ID: 22544201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda.
    Kityo C; Sigaloff KC; Sonia Boender T; Kaudha E; Kayiwa J; Musiime V; Mukuye A; Kiconco M; Nankya I; Nakatudde-Katumba L; Calis JC; Rinke de Wit TF; Mugyenyi PN
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):628-35. PubMed ID: 26723018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.
    Kuhn L; Hunt G; Technau KG; Coovadia A; Ledwaba J; Pickerill S; Penazzato M; Bertagnolio S; Mellins CA; Black V; Morris L; Abrams EJ
    AIDS; 2014 Jul; 28(11):1673-8. PubMed ID: 24785949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis of HIV in children below 18 months using DNA PCR test--assessment of the effectiveness of PMTCT interventions and challenges in early initiation of ART in a resource-limited setting.
    Gupta A; Singh G; Kaushik P; Joshi B; Kalra K; Chakraborty S
    J Trop Pediatr; 2013 Apr; 59(2):120-6. PubMed ID: 23221038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women.
    Milne RS; Silverman RA; Beck IA; Mckernan-Mullin J; Deng W; Sibley TR; Dross S; Kiarie JN; Sakr SR; Coombs RW; Chung MH; Frenkel LM
    AIDS; 2019 May; 33(6):941-951. PubMed ID: 30946148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of HIV Drug Resistance on the Selection of First- and Second-Line ART in Resource-Limited Settings.
    Bertagnolio S; Perno CF; Vella S; Pillay D
    J Infect Dis; 2013 Jun; 207 Suppl 2():S45-8. PubMed ID: 23687288
    [No Abstract]   [Full Text] [Related]  

  • 9. Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010.
    Parkin N; Bremer J; Bertagnolio S
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S266-72. PubMed ID: 22544186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique.
    Vaz P; Augusto O; Bila D; Macassa E; Vubil A; Jani IV; Pillon R; Sandstrom P; Sutherland D; Giaquinto C; Jordan MR; Bertagnolio S
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S369-74. PubMed ID: 22544205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of antiretroviral resistance in children with HIV in low- and middle-income countries.
    Fitzgerald F; Penazzato M; Gibb D
    J Infect Dis; 2013 Jun; 207 Suppl 2(Suppl 2):S85-92. PubMed ID: 23687294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
    Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.
    Bennett DE; Myatt M; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():25-36. PubMed ID: 18575189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa.
    Steegen K; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; Variava E; MacLeod W; Sanne I; Stevens WS; Carmona S
    J Antimicrob Chemother; 2017 Jan; 72(1):210-219. PubMed ID: 27659733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon.
    Aghokeng AF; Kouanfack C; Eymard-Duvernay S; Butel C; Edoul GE; Laurent C; Koulla-Shiro S; Delaporte E; Mpoudi-Ngole E; Peeters M
    J Int AIDS Soc; 2013 Jan; 16(1):18004. PubMed ID: 23374858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of dried blood spots in early diagnosis of HIV-1 infection in children born to HIV-infected mothers as part of the prevention of mother-to-child transmission in Benin].
    Tchiakpe E; Hounto-Ogouyemi A; Diop Ndiaye H; Diouara AA; Aïssi AK; Keke RK; Kpangon AA; Lafia B; Métadokou D; Bouraïma B; Anthony D; Hounsinou A; Alao MJ; Azondekon A; Ahouidi AD; Bei AK; Mbengue MA; Touré Kane C; Zannou DM
    Bull Soc Pathol Exot; 2016 Aug; 109(3):155-9. PubMed ID: 27385037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania.
    Somi GR; Kibuka T; Diallo K; Tuhuma T; Bennett DE; Yang C; Kagoma C; Lyamuya EF; Swai RO; Kassim S
    Antivir Ther; 2008; 13 Suppl 2():77-82. PubMed ID: 18575194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings.
    Ziemniak C; Mengistu Y; Ruff A; Chen YH; Khaki L; Bedri A; Simen BB; Palumbo P; Eshleman SH; Persaud D
    J Clin Microbiol; 2011 Dec; 49(12):4077-82. PubMed ID: 21956987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on successes and challenges regarding mother-to-child transmission of HIV.
    Paintsil E; Andiman WA
    Curr Opin Pediatr; 2009 Feb; 21(1):94-101. PubMed ID: 19242245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.